Orthocell received a new patent in Singapore titled “Method for Producing a Collagen Membrane and Uses Thereof,” relative to the CelGro® soft tissue reconstruction platform. The bioscaffolds have application in the repair of tendons, nerves, cartilage and bone, as well as the delivery of stem cells to surgical sites.
Orthocell has submitted CelGro for regulatory clearance in the U.S. and EU.
In 1Q17, the company entered into a research collaboration agreement with DePuy Synthes Products for its Ortho-ATI® stem cell treatment for tendon and ligament regeneration.
Orthocell received a new patent in Singapore titled "Method for Producing a Collagen Membrane and Uses Thereof," relative to the CelGro® soft tissue reconstruction platform. The bioscaffolds have application in the repair of tendons, nerves, cartilage and bone, as well as the delivery of stem cells to surgical sites.
Orthocell has submitted...
Orthocell received a new patent in Singapore titled “Method for Producing a Collagen Membrane and Uses Thereof,” relative to the CelGro® soft tissue reconstruction platform. The bioscaffolds have application in the repair of tendons, nerves, cartilage and bone, as well as the delivery of stem cells to surgical sites.
Orthocell has submitted CelGro for regulatory clearance in the U.S. and EU.
In 1Q17, the company entered into a research collaboration agreement with DePuy Synthes Products for its Ortho-ATI® stem cell treatment for tendon and ligament regeneration.
Copy to clipboard 
